SQZ BIOTECHNOLOGIES CO (SQZ) Stock Analyst Earnings Estimates
NYSE:SQZ - New York Stock Exchange, Inc. - US78472W1045 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21M 4.43% | 27.098M 29.04% | 21.478M -20.74% | 24.476M 13.96% | 81.407M 232.60% | 133.22M 63.65% | 618.98M 364.63% | 1.595B 157.68% | 2.995B 87.77% | 111.91M -96.26% | 159.48M 42.51% | |
| EBITDA YoY % growth | -49.72M -51.17% | -67.561M -35.88% | -74.321M -10.01% | 116.76M 257.10% | 129.99M 11.33% | 146.75M 12.89% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -51.06M -48.99% | -68.769M -34.68% | -75.825M -10.26% | -74.69M 1.50% | -40.047M 46.38% | -41.006M -2.40% | 223.46M 644.94% | 629.74M 181.81% | 1.536B 143.91% | -17.978M -101.17% | 18.887M 205.06% | |
| Operating Margin | -243.14% | -253.78% | -353.04% | -305.15% | -49.19% | -30.78% | 36.10% | 39.48% | 51.29% | -16.06% | 11.84% | |
| EPS YoY % growth | N/A | -2.50 49.38% | -2.60 -4.00% | -2.09 19.72% | -0.66 68.55% | -0.63 3.85% | 8.74 1,484.80% | 22.71 159.85% | 53.74 136.59% | -0.06 -100.11% | 0.07 216.67% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.61 22.31% | -0.76 1.62% | -0.74 -147.45% |
| Revenue Q2Q % growth | 2.273M -29.30% | 2.98M -13.67% | 14.342M 20.09% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.18M 19.21% | -22.675M 1.83% | -21.968M -139.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.60 20.00% | -0.55 | -0.05 | -10.01% |
| Q4 2022 Q2Q % growth | -0.30 30.23% | -0.81 | 0.51 | 62.99% |
| Q3 2022 Q2Q % growth | -0.77 3.75% | -0.84 | 0.07 | 8.70% |
| Q2 2022 Q2Q % growth | -0.78 -14.71% | -0.78 | 0.00 | 0.14% |
| Q1 2022 Q2Q % growth | -0.75 -27.12% | -0.71 | -0.04 | -4.96% |
| Q4 2021 Q2Q % growth | -0.43 59.81% | -0.70 | 0.27 | 38.48% |
| Q3 2021 Q2Q % growth | -0.80 88.62% | -0.58 | -0.22 | -37.16% |
| Q2 2021 Q2Q % growth | -0.68 | -0.59 | -0.09 | -15.58% |
| Q1 2021 Q2Q % growth | -0.59 | -0.70 | 0.11 | 15.64% |
| Q4 2020 Q2Q % growth | -1.07 | -0.74 | -0.33 | -44.47% |
| Q3 2020 Q2Q % growth | -7.03 | -1.02 | -6.01 | -589.15% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -100.00% | 3.485M | -3.485M | -100.00% |
| Q4 2022 Q2Q % growth | 11.943M -3.30% | 5.176M | 6.767M | 130.74% |
| Q3 2022 Q2Q % growth | 3.452M -27.40% | 4.291M | -839K | -19.55% |
| Q2 2022 Q2Q % growth | 3.215M -29.17% | 3.952M | -737K | -18.65% |
| Q1 2022 Q2Q % growth | 2.869M -47.36% | 4.983M | -2.114M | -42.42% |
| Q4 2021 Q2Q % growth | 12.35M 395.98% | 7.217M | 5.133M | 71.12% |
| Q3 2021 Q2Q % growth | 4.755M -22.30% | 8.655M | -3.9M | -45.06% |
| Q2 2021 Q2Q % growth | 4.539M -63.37% | 5.848M | -1.309M | -22.38% |
| Q1 2021 Q2Q % growth | 5.45M | 4.507M | 943K | 20.92% |
| Q4 2020 Q2Q % growth | 2.49M -87.62% | 3.531M | -1.041M | -29.48% |
| Q3 2020 Q2Q % growth | 6.12M | 2.636M | 3.484M | 132.17% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -22.45% | 0% | 6.91% |
| Revenue | 0% | -46.84% | 0% | 33.15% |